Company / Operating Income per Share
NovoCure Ltd Operating Income per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$1.42
FY2025
5-year range
-$2.22 / $0.29
FY2021-FY2025
Trend
+11.0%
vs FY2024
Sector context
#127 of 154
Health Care
What the data says
NovoCure Ltd's operating income per share of $-1.42 is lower than 82% of companies in the Health Care sector (FY2025). Operating Income per Share has fluctuated over the past 10 years, ranging from $-2.22 in FY2023 to $0.29 in FY2022.
Based on SEC 10-K filings.
-1.42 in FY2025.
Improved from $-2.22 to $-1.42 over the past 2 years.
Health Care sector context is included.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 18% in Health CareTop 82% of 154This company -$1.42 Sector average $4.25
▼
-133.3% below sector average
Key checks
Key Insights
- In FY2025, operating income per share increased 11.0% year-over-year.
- Ranks #127 out of 154 companies in the Health Care sector.
- Peak operating income per share was recorded in FY2022.
- Lowest operating income per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.42 | +11.0% |
| FY2024 | -$1.59 | +28.2% |
| FY2023 | -$2.22 | -858.1% |
| FY2022 | $0.29 | +3373.8% |
| FY2021 | -$0.01 | +97.4% |
| FY2020 | -$0.34 | +19.8% |
| FY2019 | -$0.42 | +67.3% |
| FY2018 | -$1.29 | -7.9% |
| FY2017 | -$1.19 | -24.8% |
| FY2016 | -$0.96 | +80.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026